Saraca indica Bark Extract Shows In Vitro Antioxidant, Antibreast Cancer Activity and Does Not Exhibit Toxicological Effects

Table 5

Haematological results on day 15 of oral gavage administration of 500, 1000, 1500, and 2000 mg/Kg B.Wt. of SIE to female CF rats. NS represent no statistical significant differences, when the test groups were compared to the control group.

	Parameter	Control group	500 mg/Kg B.Wt.	1000 mg/Kg B.Wt.	1500 mg/Kg B.Wt.	2000 mg/Kg B.Wt.	value
		Mean ± SD	Mean ± SD	Mean ± SD	Mean ± SD	Mean ± SD
1	Hgb (g/dL)	12.63 ± 0.50	12.68 ± 0.66	13.16 ± 0.38	13.16 ± 1.00	12.80 ± 0.80	NS
2	T-RBC (×10^6/mm^3)	6.76 ± 0.26	5.99 ± 0.49	5.99 ± 0.49	6.72 ± 0.49	6.44 ± 0.82	NS
3	MCV (micron^3)	56.90 ± 2.10	57.08 ± 1.56	57.42 ± 1.78	54.75 ± 1.81	55.02 ± 1.77	NS
4	HCT (%)	38.47 ± 0.37	34.23 ± 2.06	34.40 ± 2.73	36.80 ± 2.88	35.35 ± 3.30	NS
5	MCH (pg)	20.33 ± 1.25	21.15 ± 0.37	22.12 ± 1.42	19.60 ± 1.10	20.00 ± 1.64	NS
6	MCHC (g/dL)	35.67 ± 1.01	37.08 ± 0.41	38.48 ± 1.94	35.85 ± 1.00	36.32 ± 2.24	NS
7	WBC ×10^3	5.35 ± 1.03	5.07 ± 0.76	4.88 ± 1.22	5.08 ± 1.95	5.32 ± 1.05	NS
8	RDW	8.87 ± 1.32	10.45 ± 0.33	9.40 ± 0.96	8.67 ± 1.02	10.81 ± 1.42	NS
9	MPV	4.00 ± 0.36	4.02 ± 0.33	4.26 ± 0.09	4.45 ± 0.13	4.24 ± 0.09	NS
10	PLT (×10^3/mm^3)	736.3 ± 47.20	759.0 ± 67.56	750.8 ± 84.40	796.8 ± 39.34	742.4 ± 74.48	NS